Posts

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study

/in /by

The optimum treatment for high-risk soft-tissue sarcoma (STS) in adults is unclear. Regional hyperthermia concentrates the action of chemotherapy within the heated tumour region. Phase 2 studies have shown that chemotherapy with regional hyperthermia improves local control compared with chemotherapy alone. We designed a parallel-group randomised controlled trial to assess the safety and efficacy of regional hyperthermia with chemotherapy.

Read more

Results in brain tumors with locoregional RF hyperthermia in the GIMT

/in /by

In contrast to the enormous therapeutic efforts, the results of conventional treatments for highly malignant brain tumors (gliomas) are rather unsatisfactory. The prognosis for this tumor type is poor, its median overall survival (6-14 months) is less than one year (1,2,5,6,8). Most of the cases are inoperable, or only partial removal is possible, and the […]

Read more